期刊文献+

迈瑞H50糖化血红蛋白分析仪精密度和可比性评估 被引量:2

Precision and comparability assessment of Mindray H50 glycated hemoglobin A_(1c) analyzer
下载PDF
导出
摘要 目的评估迈瑞H50糖化血红蛋白分析仪(简称H50)的精密度和方法间的可比性。方法依据美国临床实验室标准化协会(CLSI)EP5-A2和EP9-A2文件对H50的精密度进行评价,同时与TOSOH HLC-723 G8糖化血红蛋白分析仪(简称G8)进行比对。结果 H50测定糖化血红蛋白(HbA_(1c))高、低值临床样本的批内、批间、天间和总精密度[以变异系数(CV)表示]分别为0.34%、0.77%、0.60%、1.03%和0.86%、1.55%、0.00%、1.72%,与G8具有良好的可比性(Y_(H50)=1.053 3X_(G8)-0.486 7,r=0.998 4),在Hb A1c水平分别为4.0%、6.0%、6.5%、7.0%和9.0%时与G8的绝对偏差[95%可信区间(CI)]分别为-0.27%(-0.30%^-0.25%)、-0.17%(-0.18%^-0.15%)、-0.14%(-0.16%^-0.12%)、-0.11%(-0.13%^-0.10%)、-0.01%(-0.02%~0.01%)。结论 H50的精密度良好,与G8的检测结果具有可比性,能满足糖尿病诊断和监测的要求。 Objective To evaluate the precision and comparability of Mindray H50 glycated hemoglobin A1c(HbA1c)analyzer. Methods According to the Clinical and Laboratory Standards Institute(CLSI) EP5-A2 and EP9-A2,the precision and comparability of H50 were evaluated and compared with TOSOH HLC-723 G8 analyzer.Results The within-run,between-run,inter-day and total precisions [coefficients of variation(CV)] for clinical samples with high and medium values of HbA1c were 0.34%,0.77%,0.60%,1.03% and 0.86%,1.55%,0.00%,1.72%,respectively. There was a good comparability between H50 and G8(YH50=1.053 3XG8-0.486 7,r=0.998 4).The biases [95% confidence interval(CI)] were -0.27%(-0.30%--0.25%),-0.17%(-0.18%--0.15%),-0.14%(-0.16%--0.12%),-0.11%(-0.13%--0.10%),-0.01%(-0.02%-0.01%)at different HbA1c levels of 4.0%,6.0%,6.5%,7.0% and 9.0%. Conclusions H50 has a good precision and shows a correlation with G8,and it meets the requirements of the diagnosis and glucose monitoring for diabetes mellitus.
作者 郭宗辉 陈永强 曾方银 GUO Zonghui;CHEN Yongqiang;ZENG Fangyin(Department of Clinical Laboratory,Peking University Care Luzhong Hospital,Zibo 255400,Shandong,China;Department of Clinical Laboratory,the Fifth Affiliated Hospital of Southern Medical University,Guangzhou 510515,Guangdong,China)
出处 《检验医学》 CAS 2017年第3期214-218,共5页 Laboratory Medicine
关键词 糖化血红蛋白 糖尿病 精密度 可比性 Glycated hemoglobin A1c Diabetes mellitus Precision Comparability
  • 相关文献

参考文献1

二级参考文献39

  • 1中国合格评定国家认可委员会.已获认可机构名称[EB/OL].[2010-12-29]http://219.238.178.49/Acc_Search2.asp?Class=L.
  • 2中华医学会糖尿病学分会.中国2型糖尿病防治指南[M].北京:北京大学医学出版社,2013:447-498.
  • 3International Diabetes Federation. IDF annual report 2013 [ EB/OL ]. ( 2014-07-23 ) [ 2014-12-28 ]. http ://www. idf. org/publieations/annual-report.
  • 4International Diabetes Federation. China [ EB/OL ]. (2015-03-15) [ 2015-03-16 ]. http ://www. idf. org/ membership/wp/ehina.
  • 5World Health Organization. Department of noncommunicable disease surveillance. Definition, diagnosis and classification of diabetes mellitus and its complication. Report of a WHO consultation. Partl : Diagnosis and classification of diabetes mellitus [ R ]. Geneva- WHO, 1999.
  • 6WESTGARD QC. Quality requirements: desirable biological variation database specifications[ EB/OL]. (2015-03-15) [ 2015-03-16 ]. http://www. westgard, com/biodatabasel, htm.
  • 7UK Prospective Diabetes Study ( UKPDS ) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33 ) [ J ]. Lancet, 1998,352 ( 9131 ): 837- 853.
  • 8The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long- term complications in insulin-dependent diabetes mellitus[ J ]. N Engl J Med, 1993,329 (14) : 977- 986.
  • 9RAHBAR S. An abnormal hemoglobin in red cells of diabetics [ J ]. Clin Chim Acta, 1968,22 ( 2 ) : 296- 298.
  • 10STRATI'ON IM, ADLER AI, NEIL HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes ( UKPDS 35 ) : prospective observational study [ J ]. BMJ,2000,321 (7258) :405-412.

共引文献15

同被引文献12

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部